Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization

Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization

Background/Purpose: This study is to use albumin-bilirubin (ALBI) grade and up-to-7 (UT7) criteria to assess outcomes of patients with intermediate stage hepatocellular carcinoma (HCC) after transarterial (chemo)embolization (TA(C)E). Methods: Between January 2012 and January 2019, newly diagnosed i...

Full description

Bibliographic Details
Main Authors: Hsin-Yeh Chen, Kwong-Ming Kee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Yuan-Hung Kuo
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Journal of the Formosan Medical Association
Subjects:
Albumin-bilirubin grade
Hepatocellular carcinoma
Intermediate stage
Transarterial embolization
Up-to-7
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664621003156

Internet

http://www.sciencedirect.com/science/article/pii/S0929664621003156

Similar Items